Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,232 | 3,405 | 1,079 | 10,775 | 3,460 |
| Marketable Securities | 20,734 | 25,998 | 28,604 | 19,460 | 27,434 |
| Receivables | 333 | 350 | 330 | 265 | 465 |
| TOTAL | $29,299 | $29,753 | $30,013 | $30,500 | $31,359 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 15,016 | 15,014 | 15,013 | 15,015 | 15,013 |
| TOTAL | $15,016 | $15,014 | $15,013 | $15,015 | $15,013 |
| Total Assets | $44,315 | $44,767 | $45,026 | $45,515 | $46,372 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37 | 253 | 95 | 222 | 214 |
| Other current liabilities | 908 | 1,388 | 1,577 | 1,870 | 2,245 |
| TOTAL | $945 | $1,641 | $1,672 | $2,092 | $2,459 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43,269 | 43,126 | 43,256 | 43,423 | 43,913 |
| TOTAL | $43,269 | $43,126 | $43,256 | $43,423 | $43,913 |
| Total Liabilities | $45,260 | $44,767 | $46,698 | $45,515 | $46,372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,235 | 8,235 | 8,235 | 8,235 | 8,235 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $45,260 | $44,767 | $46,698 | $45,515 | $46,372 |